Menú Principal Inscripción de nuevos miembros Estudios GICOR
Información sobre GICOR Simposios y Congresos Enlaces de Interés
Acceso a zona restringida a socios Publicaciones GICOR Contactar con GICOR
   
     
 
Últimas Publicaciones Gicor Publicaciones Gicor Publicaciones Miembros Gicor
 
Últimas Publicaciones GICOR
   
 
Erlotinib and chemoradiation in patients with surgically resected locally advanced squamous cell carcinoma of the head and neck: a GICOR phase I trial.
Arias de la Vega F, Contreras J, de Las Heras M, de la Torre A, Arrazubi V, Herruze I, Prieto I, García-Saenz JA, Romero J, Calvo FA; Members of the GICOR (Grupo de Investigación Clínica en Oncología Radioterápica) group. Ann Oncol. 2011 Jul 21. [Epub ahead of print] PMID: 21778302 [PubMed - as supplied by publisher].
Estudio Epidemiológico sobre la prevalencia de Candidiasis Orofaríngea en pacientes con cáncer de cabeza y cuello atendidos en hospitales españoles. Estudio ICARO, SEOR 2011.
Phase III trial comparing long-term versus short-term androgen deprivation combined with high-dose radiotherapy for localized prostate cancer: GICOR protocol DART01/05. SEOR 2011.ART 01/05

 

 

Últimas Publicaciones Gicor Publicaciones Gicor Publicaciones Miembros Gicor
 
Publicaciones GICOR
   
 

BRACHYTHERAPY IN SKING CANCER
Silvia Rodriguez MD. PhD. Instituto para el tratamiento integral del cncer ITIC. - Hospital Clnica Benidorm (Alicante)

ERLOTINIB AND CHEMORADIATION IN PATIENTS WITH SURGICALLY RESECTED LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN): A GICOR PHASE I TRIAL
F. Arias de la Vega1*, I. Herruzo2, M. de las Heras3, A. de la Torre4, V. Arrazubi1, J. Contreras2, I. Prieto5, J. A. Garca Saenz3, J. Romero4, F. A. Calvo5

POSTER ESMO 2008. LONG-TERM VERSUS SHORT-TERM ANDROGEN DEPRIVATION COMBINED WITH HIGH-DOSE CONFORMAL RADIOTHERAPY FOR PATIENTS WITH LOCALIZED PROSTATE CANCER: FIRST REPORT ON COMPLIANCE, FEASIBILITY
A. Zapatero, A. Alvarez, X. Maldonado, A. Guerrero, V. Macas, A. Cabeza, C. Gonzlez San-Segundo, F. Casas, A. Pedro Oliv, F.A. Calvo

Gua Teraputica de Soporte en Oncologa adioterpica (509 pg). Ed. Masson. Barcelona 2004. ISBN:84-458-1419-2
PREZ ROMASANTA LA, CALVO FA

Pathologic downstaging of T3-4Nx rectal cancer after chemoradiation: 5-Fluorouracil vs Tegafur. Int J Radiat Oncol Biol Phys 51: 1264 - 1270, 2001. FI: 4.556
CALVO FA, GMEZ-ESPI M, DAZ-GONZLEZ JA, CANTALAPIEDRA R, MARCOS P, ALVARADO A, GARCA-ALFONSO P, HERRANZ R, LVAREZ E.

Intraoperative presacral electron boost following preoperative chemoradiation in T3-4Nx rectal cancer: initial local effects and clinical outcome analysis. Radiother Oncol 62:201-206, 2002. FI: 3.304
CALVO FA, GMEZ-ESPI M, DAZ GONZLEZ JA, ALVARADO A, CANTALAPIEDRA R, MARCOS P, MATUTE R, MARTINEZ NE, LOZANO MA, HERRANZ R

18F-FDG Positron emission tomography staging and restaging in rectal cancer treated with preoperative chemoradiation. Int J Radiat Oncol Biol Phys 58:528-535, 2004. FI: 4.556
CALVO FA, DOMPER M, MATUTE R, MARTNEZ-LZARO R, ARRANZ JA, DESCO M, LVAREZ E, CARRERAS JL

Neoadjuvant chemoradiation with Tegafur in cancer of the pancreas. Initial analysis of clinical tolerance and outcome. Am J Clin Oncol 27:343-349, 2004. FI: 1.615
CALVO FA, MATUTE R, GARCA-SABRIDO JL, GMEZ-ESP M, MARTNEZ N, LOZANO MA, HERRANZ R

Preoperative chemoradition with oral tegafur within a multidisciplinary therapeutic approach in patients with T3-4 rectal cancer. Int J Radiat Oncol Biol Phys 61:1378-1384, 2005. FI: 4.556
DAZ-GONZLEZ JA, CALVO FA, CORTS J, DE LA MATA D, GMEZ-ESP M, LOZANO MA, LOZANO E, SERRANO J, HERRANZ R

Risk-adapted androgen deprivation and escalated three-dimensional conformal radiotherapy for prostate cancer: does radiation dose influence out come of patients treated with adjuvant androgen deprivat
ZAPATERO A, VALCARCEL F, CALVO FA, ALGAS R, BEJAR A, MALDONADO J, VILL S

Prognostic factors for disease-free survival in patients with T3-4 or N+ rectal cancer treated with preoperative chemoradiation, surgery and intraoperative irradiation. Int J Radiat Oncol Biol Phys 64
DAZ-GONZLEZ JA, CALVO FA, CORTS J, GARCA-SABRIDO JL, GMEZ-ESP M, DEL VALLE E, MUOZ-JIMNEZ F, LVAREZ E

Improved incidence of p T0 downstaged surgical specimen in locally advanced rectal cancer (LARC) treated with induction oxaliplatin plus 5-fluorouracil and preoperative chemoraditation. Ann Oncol 17:1
CALVO FA, SERRANO FJ, DAZ-GONZLEZ JA, GMEZ-ESP M, LOZANO E, GARCA R, DE LA MATA D, ARRANZ JA, GARCA-ALFONSO P, PREZ-MANGA G, LVAREZ E

A large, multinational, prospective survey defining the prevalence, incidence and treatment of anemia in cancer patients. Eur J Cancer 40:2293-2306, 2004 FI: 3.806
EUROPEAN CANCER ANEMIA SURVEY (ECAS)

- The expression of epidermal growth factor receptor results in a worse prognosis for patients with rectal cancer treated with preoperative radiotherapy: a multicenter, restrospective analysis
JORDI GIRALT, MANUEL DE LAS HERAS, LAURA CEREZO, ARANZAZU ERASO, EDUARDO HERMOSILLA, DOLORES VELEZ, JUAN LUJAN, ELOI ESPIN, JOSE ROSSELLO, JOAQUIN MAJ, SERGI BENAVENTE, MANEL ARMENGOL, I. DE TORRES, ON BEHALF OF THE GRUPO ESPAOL DE INVESTIGACIN CLNICA EN ONCOLOGA RADIOTERPICA (GICOR)

- Phase II trial: concurrent radio-chemotherapy with weekly docetaxel for advanced squamous cell carcinoma of head and neck
A. BIETE SOL, J. MARRUECOS QUEROL, F.A. CALVO MANUEL, E. VERGER FRANSOY, . ROVIROSA CASINO, J.J. GRAU DE CASTRO, M. DE LAS HERAS GONZLEZ, A. RAMOS AGUERRI, A. PALACIOS EITO, C. VEIRAS CANDAL AND M. V. SOLANO LPEZ

- Predictive factors in advanced head and neck cancer treated by radio-chemotherapy and hypoxia modification
B. Clavo, F. Robaina, A. Ruiz, M. Lloret, D. Macias, J. Rivero, B. Pinar, S. Quintero, J. M. Cuyas and M. A. Hernandez
Dr. Negrin University Hospital, Las Palmas, Spain

 

Últimas Publicaciones Gicor Publicaciones Gicor Publicaciones Miembros Gicor
 
Publicaciones Miembros GICOR
   
 

Effectiveness of opioid rotation in the control of cancer pain: The ROTODOL Study.
· González-Barboteo J, Gómez-Batiste Alentorn X, Calvo Manuel FA, Alberola Candel V, Palacios Eito A, Sánchez-Magro I, Neira Álvarez M, Pérez Martín FJ,Porta-Sales J, on behalf of the ROTODOL Study GroupJournal of Opioid Management 10:6 n November/December 2014
.

Brain ischemia and hypometabolism treated by ozone therapy.
· Clavo B, Suarez G, Aguilar Y, Gutierrez D, Ponce P, Cubero A, Robaina F, Carreras JL.
· Forsch Komplementmed. 2011;18(5):283-7. doi: 10.1159/000333795. Epub 2011 Oct 13.

>PMID: 22105041.

Persistent PORT-A-CATH®-related fistula and fibrosis in a breast cancer patient successfully treated with local ozone application.
· Clavo B, Santana-Rodriguez N, López-Silva SM, Dominguez E, Mori M, Gutierrez D, Hernandez MA, Robaina F.
· J Pain Symptom Manage.2012 Feb; 43(2):e3-6. No abstract available.

>PMID: 22248793.

F-FDG PET bio-metabolic monitoring of neoadjuvant therapy effects in rectal cancer: Focus on nodal disease characteristics.
· Felipe A. Calvo a, Luis Cabezón a, Carmen González a, Alicia Soria a, Dolores de la Mata a, Marina Gómez-Espí a, Pilar García-Alfonso a, Emilio Álvarez b, José Luis Carreras c.
· a Department of Oncology; and b Department of Pathology, Hospital General Universitario Gregorio Marañón, Madrid, Spain; c Department of Radiology and Medical Physics, School of Medicine, Complutense University, Madrid, Spain.
Modification of loco-regional microenvironment in brain tumors by spinal cord stimulation. Implications for radio-chemotherapy.
· Clavo B, Robaina F, Valcarcel B, Catala L, Perez JL, Cabezon A, Jorge IJ, Fiuza D, Hernandez MA, Jover R, Carreras JL.
· J Neurooncol. 2011 Jul 12.
PMID: 21748490.
Epoetins and mortality in patients with cancer.
· Clavo B, Santana N, Biete A.
· Lancet. 2009 Jul 25;374(9686):287; author reply 287-8. No abstract available.
PMID: 19632483
Modification of glucose metabolism in radiation-induced brain injury areas using cervical spinal cord stimulation.
· Clavo B, Robaina F, Montz R, Carames MA, Lloret M, Ponce P, Hernandez MA, Carreras JL.
· Acta Neurochir (Wien). 2009 Nov;151(11):1419-25. Epub 2009 Jun 5.
PMID: 19499176
Effect of cervical spinal cord stimulation on cerebral glucose metabolism.
· Clavo B, Robaina F, Montz R, Carames MA, Otermin E, Carreras JL.
· Neurol Res. 2008 Jul;30(6):652-4. Epub 2008 May 29.

PMID: 18513465

The role of spinal cord stimulation in the management of patients with brain tumors.
· Robaina F, Clavo B.
· Acta Neurochir Suppl. 2007;97(Pt 1):445-53. Review.
PMID: 17691408
Spinal cord stimulation in the treatment of post-stroke patients: current state and future directions.
· Robaina F, Clavo B.
· Acta Neurochir Suppl. 2007;97(Pt 1):277-82. Review.
PMID: 17691387
Do erythropoietin receptors on cancer cells explain unexpected clinical findings?
· Clavo B.
· J Clin Oncol. 2007 Apr 10;25(11):1447-8; author reply 1448. No abstract available.
PMID: 17416869
Cerebral blood flow increase in cancer patients by applying cervical spinal cord stimulation.
· Clavo B, Robaina F, Catal? L, Lloret M, Pinar B, Caram?s MA, Ruiz A, Cabez?n A, Gonz?lez G, Lara P, Ruiz-Egea E, Hern?ndez MA.
· Neurocirugia (Astur). 2007 Feb;18(1):28-32; discussion 33-5.
PMID: 17393043
Modification of glucose metabolism in brain tumors by using cervical spinal cord stimulation.
· Clavo B, Robaina F, Montz R, Domper M, Carames MA, Morera J, Pinar B, Hernandez MA, Santullano V, Carreras JL.
· J Neurosurg. 2006 Apr;104(4):537-41.
PMID: 16619657

 

 

 
     
 
· AVISO LEGAL · © GICOR - Grupo de Investigación Clínica en Oncología Radioterápica · C/CHILE, 10 - C.P.- 28290 LAS ROZAS, MADRID - ESPAÑA. · email: gicor@serini3.es